Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · Real-Time Price · USD
0.727
-0.006 (-0.83%)
At close: Nov 1, 2024, 4:00 PM
0.606
-0.121 (-16.62%)
After-hours: Nov 1, 2024, 7:04 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $3.55 million as of November 1, 2024. Its market cap has decreased by -62.20% in one year.
Market Cap
3.55M
Enterprise Value
1.68M
1-Year Change
-62.20%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from $45.09M to $3.55M, a decrease of -92.12%. That is a compound annual growth rate of -49.61%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 1, 2024 | 3.60M | -2.70% |
Dec 29, 2023 | 3.70M | -49.32% |
Dec 30, 2022 | 7.30M | -81.84% |
Dec 31, 2021 | 40.20M | -10.84% |
Feb 17, 2021 | 45.09M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chromocell Therapeutics | 3.70M |
NovaBay Pharmaceuticals | 3.66M |
Titan Pharmaceuticals | 3.66M |
Ainos | 3.66M |
Bio-Path Holdings | 3.64M |
InMed Pharmaceuticals | 3.48M |
NuCana | 3.46M |
Biodexa Pharmaceuticals | 3.43M |